Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Piazza

Showing results (371-380 of 402) with videos related to

Pageof 41
Sort By:
Cancers|September 27, 2025
Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor ModelsDaniela D De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 28, 2009
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activityGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 26, 2011
Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009P Pezzotti, C Piovesan, L Barzon, et al.
BMC Infectious Diseases|August 28, 2020
Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literatureM Carugati, A Piazza, A M Peri, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 6, 2019
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancerAleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Cancers|February 11, 2023
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in RatsHeather N Tinsley, Bini Mathew, Xi Chen, et al.
Journal of Neurosurgery|October 18, 2011
Evaluation of intraventricular hemorrhage assessment methods for predicting outcome following intracerebral hemorrhageBrian Y Hwang, Samuel S Bruce, Geoffrey Appelboom, et al.
Digestive Diseases and Sciences|October 26, 2016
Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic EsophagitisW Asher Wolf, Nicholas A Piazza, Jessica H Gebhart, et al.
Molecular Cancer Therapeutics|June 28, 2013
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signalingNan Li, Yaguang Xi, Heather N Tinsley, et al.
Cancers|June 12, 2026
Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading ResistanceSindhu Ramesh, Junwei Wang, Chung-Hui Huang, et al.
Pageof 41

Showing results (371-380 of 402) with videos related to

Sort By:
Pageof 41
Cancers|September 27, 2025
Evaluation of a Novel Pan-RAS Inhibitor in 3D Bioprinted Tumor ModelsDaniela D De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 28, 2009
A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activityGary A Piazza, Adam B Keeton, Heather N Tinsley, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 26, 2011
Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009P Pezzotti, C Piovesan, L Barzon, et al.
BMC Infectious Diseases|August 28, 2020
Fatal respiratory infection due to ST308 VIM-1-producing Pseudomonas aeruginosa in a lung transplant recipient: case report and review of the literatureM Carugati, A Piazza, A M Peri, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 6, 2019
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancerAleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Cancers|February 11, 2023
Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in RatsHeather N Tinsley, Bini Mathew, Xi Chen, et al.
Journal of Neurosurgery|October 18, 2011
Evaluation of intraventricular hemorrhage assessment methods for predicting outcome following intracerebral hemorrhageBrian Y Hwang, Samuel S Bruce, Geoffrey Appelboom, et al.
Digestive Diseases and Sciences|October 26, 2016
Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic EsophagitisW Asher Wolf, Nicholas A Piazza, Jessica H Gebhart, et al.
Molecular Cancer Therapeutics|June 28, 2013
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signalingNan Li, Yaguang Xi, Heather N Tinsley, et al.
Cancers|June 12, 2026
Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading ResistanceSindhu Ramesh, Junwei Wang, Chung-Hui Huang, et al.
Pageof 41